HIGHLIGHTS
- Irregular Heart Rhythm Notifications will notify consumers of a heart problem.
- Fitbit analyzes users' hearing rhythms while they are motionless or asleep. According to Fitbit, the function is not intended for usage by persons under the age of 22.
Fitbit has begun to deploy Irregular Heart Rhythm Notifications across nine of its devices. Fitbit got approval from the US Food and Drug Administration (FDA) earlier this month for the company's new photoplethysmography (PPG) algorithm to detect atrial fibrillation (AFib). This new algorithm will be used to power the new Fitbit wearable function. Users who get the message will also be prompted to take the following actions. Fitbit Sense, Fitbit Versa 3, and Fitbit Luxe are among the smartwatches that enable the new functionality. The firm has said that the alerts function is not intended for persons under the age of 22.
Fitbit's Irregular Cardiac Rhythm Notifications will notify consumers of a possible heart problem. Fitbit's latest tool analyzes users' cardiac rhythms while they are motionless or sleeping, looking for potential indicators of AFib.
Fitbit gained FDA approval for its updated PPG algorithm on April 11, as previously stated. The PPG algorithm is used to detect AFib and power the new Irregular Heart Rhythm Notifications.
When a user receives the Irregular Heart Rhythm Notifications, they will be prompted to visit a healthcare practitioner and not to modify the user's prescription or existing healthcare regimen without first consulting with a healthcare provider.
The feature is currently available in the United States and works with nine Fitbit devices: Fitbit Sense, Fitbit Versa 2, Fitbit Versa 3, Fitbit Versa Lite, Fitbit Charge 3, Fitbit Charge 4, Fitbit Charge 5, Fitbit Luxe, and Fitbit Inspire 2.
